Half-year report · Q2
6788.TEDINET S100URRH
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥20.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥1.9bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥1.7bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.9bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥3.2bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.1bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.8bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.3bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.2bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.5bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥1.2bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥32.6bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥31.5bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥30.1bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.2bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥7.9bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥24.4bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥23.6bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥22.5bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥15.7bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥15.7bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.3bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.8bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥883m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥149m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥703m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥998m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥985m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥170.4 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥280.51 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥155.76 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 70.3% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.7% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.0% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥215m |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥9.9bn |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥9.9bn |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.6bn |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥11.4bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥11.4bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E02333-000Medical Relatedreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥194m |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥9.2bn |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥9.2bn |
| jpcrp040300-q2r_E02333-000Water Health Carereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.5bn |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥10.5bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥10.5bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥1.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 506
| Item | Context | Value | Unit |
|---|---|---|---|
| Salaries and allowances sga | Prior1YTDDuration | 1122979000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 1189594000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 140743000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 151911000 | JPY |
| Provision for share based payments sga | Prior1YTDDuration | 36500000 | JPY |
| Provision for share based payments sga | CurrentYTDDuration | 38417000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 49134000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 52226000 | JPY |
| Provision for directors retirement benefits sga | Prior1YTDDuration | 9939000 | JPY |
| Provision for directors retirement benefits sga | CurrentYTDDuration | 14243000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02333-000WaterHealthCareReportableSegmentsMember | 9160245000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02333-000MedicalRelatedReportableSegmentsMember | 1292529000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 10452775000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 10452775000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02333-000WaterHealthCareReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02333-000MedicalRelatedReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02333-000WaterHealthCareReportableSegmentsMember | 9160245000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02333-000MedicalRelatedReportableSegmentsMember | 1292529000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 10452775000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 10452775000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02333-000WaterHealthCareReportableSegmentsMember | 1491902000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02333-000MedicalRelatedReportableSegmentsMember | 194288000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 1686191000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Operating income | Prior1YTDDuration | 1686191000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02333-000WaterHealthCareReportableSegmentsMember | 9943038000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02333-000MedicalRelatedReportableSegmentsMember | 1418271000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 11361310000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 11361310000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02333-000WaterHealthCareReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02333-000MedicalRelatedReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02333-000WaterHealthCareReportableSegmentsMember | 9943038000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02333-000MedicalRelatedReportableSegmentsMember | 1418271000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 11361310000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | CurrentYTDDuration | 11361310000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02333-000WaterHealthCareReportableSegmentsMember | 1641734000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02333-000MedicalRelatedReportableSegmentsMember | 214781000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 1856516000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Operating income | CurrentYTDDuration | 1856516000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |